Takeda Pharmaceutical Company Limited
6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD
Last updated:
Abstract:
The present invention provides compounds of the formula: ##STR00001## which are useful as inhibitors of PHD, pharmaceutical compositions thereof, methods for treatment of conditions associated with HIF, processes for making the compounds and intermediates thereof.
Status:
Grant
Type:
Utility
Filling date:
1 Mar 2018
Issue date:
10 Sep 2019